<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<?OntoDPSData docID="3374916" markupID="2092790" OntoTechnologyVersion="3.59.92.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:BasicEntity="http://www.abbyy.com/ns/BasicEntity#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:Aux="http://www.abbyy.com/ns/Aux#">
	<BasicEntity:MoneySimplified rdf:nodeID="bnodeB23AA522-1E7E-417D-80DC-B5D7F199D474">
		<BasicEntity:ms_major_currency xml:lang="en-US">Euro</BasicEntity:ms_major_currency>
		<BasicEntity:ms_major_amount xml:lang="en-US">5550000</BasicEntity:ms_major_amount>
	</BasicEntity:MoneySimplified>
	<Aux:TextAnnotations rdf:nodeID="bnode8A3DDAD1-24E0-40C7-B742-6D8E22A96AF7">
		<Aux:document_text xml:lang="en-US">Dear shareholders, dear business partners, after an extremely successful fiscal year 2003/2004 biolitec AG managed in the first three months of the actual fiscal year to display a slight positive trend in spite of the Dollar decline (around 50% of our business is conducted in Dollars or related currencies). Consolidated turnover amounted to Euro 5.55 millions. Due to the weak summer months this turnover is not suitable for an extrapolation. ELVeS™ vein treatment system and disposables showed good results in particular. The highest percentage gains of +21% were recorded by Foscan®, the anticancer drug. Again laser fibres and probes were the major sales item. North America and Europe contributed in significant dimensions to the consolidated turnover. During this first quarter the North American share of overall sales was 44 percent and the European share 51 percent. A significant increase of +52% was reached by Asia and the Rest of the World.</Aux:document_text>
		<Aux:annotation>
			<Aux:InstanceAnnotation rdf:nodeID="bnodeA10663E3-405E-4AE1-9C75-833FDA810844">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">343</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">361</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnodeB23AA522-1E7E-417D-80DC-B5D7F199D474"/>
			</Aux:InstanceAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnode916F464E-359B-4986-8B49-B347AFF41557">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">343</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">347</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnodeB23AA522-1E7E-417D-80DC-B5D7F199D474"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_currency</Aux:property_name>
				<Aux:property_value xml:lang="en-US">Euro</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
		<Aux:annotation>
			<Aux:PropertyAnnotation rdf:nodeID="bnode74C644BA-AF11-4CF4-91AB-D01390509D37">
				<Aux:annotation_start rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">348</Aux:annotation_start>
				<Aux:annotation_end rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">361</Aux:annotation_end>
				<Aux:instance rdf:nodeID="bnodeB23AA522-1E7E-417D-80DC-B5D7F199D474"/>
				<Aux:property_name xml:lang="en-US">http://www.abbyy.com/ns/BasicEntity#ms_major_amount</Aux:property_name>
				<Aux:property_value xml:lang="en-US">5550000</Aux:property_value>
			</Aux:PropertyAnnotation>
		</Aux:annotation>
	</Aux:TextAnnotations>
</rdf:RDF>